Skip to main content
Equibles

ALPS ADVISORS INC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1376113 Denver, CO
Back to BCRX Full portfolio

Position in BCRX

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$3,179,600
+$2,606,020 QoQ
Shares Held
317,960
+427.7% QoQ
Ownership
0.124%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#81
of 319 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $10,837,032 across 10 Drug Manufacturers - Specialty & Generic names. BCRX ranks #1 (29.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BCRX
Biocryst Pharmaceuticals Inc
This page 		317,960 $3,179,600
2 ZTS
Zoetis Inc.
 29,756 $2,138,266
3 AMLX
Amylyx Pharmaceuticals, Inc.
 112,447 $2,019,548
4 RDY
Dr Reddys Laboratories Ltd
 54,068 $783,445
5 UTHR
UNITED THERAPEUTICS Corp
 1,405 $761,271
6 ANIP
Ani Pharmaceuticals Inc
 7,125 $589,807
7 COLL
Collegium Pharmaceutical, Inc
 14,552 $526,782
8 PAHC
Phibro Animal Health Corp
 10,131 $318,113

All Filings in BCRX

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,179,600 317,960
2026-03-31 $573,580 60,250
2025-09-30 $767,538 101,125
2025-06-30 $1,011,001 112,835
2025-03-31 $1,147,387 152,985
2024-12-31 $1,259,539 167,492
2024-09-30 $1,201,636 158,110
2024-06-30 $994,998 161,003
2024-03-31 $738,662 145,406
2023-12-31 $827,224 138,101
2023-09-30 $990,138 139,850
2023-06-30 $977,701 138,878
2023-03-31 $1,024,302 122,818
2022-12-31 $1,450,762 126,373
2022-09-30 $1,279,391 101,539
2022-06-30 $1,165,016 110,115